The strength of our unique Group lies mainly in the willingness of participating public institutions to pool their strengths, expertise and experiences with respect to best practices based on Research that cares.
It is this common willingness, combined with the support of several leading partners, which also allows us to launch innovative initiatives with and for people suffering from breast cancer.
In keeping with our mission, the initiatives we set up rise from the priorities established by the members of our board of directors and our scientific committee, who are experts in their respective fields.
Our initiatives for Research that cares:
- Initiated by its Scientific Committee, and under the leadership of Dr. Sarkis Meterissian, the McPeak-Sirois Group set up the first Quebec Metastatic Breast Cancer Registry, which benefits from the full support of the Ministère de la Santé et des Services sociaux (MSSS) as well as of the Direction nationale du Programme québécois de cancérologie. Launched in 2021 with the financial support of four pharmaceutical companies and the Quebec Breast Cancer Foundation, the Registry will be extended in 2022 to the seven other member hospitals of the consortium thanks to the support of the Canadian Cancer Society, which has become its lead sponsor and to the continued support of the pharmaceutical companies.
Learn more about the Quebec Metastatic Breast Cancer Registry
- In close collaboration with the CIUSSS de l’Estrie-CHUS, a Patient-Partner committee in clinical research on breast cancer was created by the Group to promote clinical research as a treatment option and to optimize participation in trials. The setting up of this committee is the logical and natural continuation of the Group’s contribution to the important and essential reflection on patient and patient group engagement in clinical trials in oncology1.